Potent antimyeloma activity of a novel ERK5/CDK inhibitor.

Saved in:
Bibliographic Details
Title: Potent antimyeloma activity of a novel ERK5/CDK inhibitor.
Authors: Álvarez-Fernández S; Instituto de Biología Molecular y Celular del Cáncer, CSIC-IBSAL-Universidad de Salamanca, Spain., Ortiz-Ruiz MJ, Parrott T, Zaknoen S, Ocio EM, San Miguel J, Burrows FJ, Esparís-Ogando A, Pandiella A
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 May 15; Vol. 19 (10), pp. 2677-87. Date of Electronic Publication: 2013 Mar 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-12-2118